Global Colon Cancer Association Logo
  • About us
    Who we are
    AboutLeadershipProgram overview
    Our members
    Member OrganizationsCorporate MembersBecome a memberFind a member
    Our programs
    Know Your BiomarkerTransforming PolicyGlobal CRC CongressCRC Health Equity GrantsPatient Advocacy MentorshipClinical Trial AwarenessColon Cancer ConnectedGlobal Ostomy Program
    GCCA Membership Hub Preview

    GCCA Membership Hub

    Your place for collaboration, resource-sharing, and community across the global CRC network.
    Learn more
    Arrow Right
  • About colorectal cancer
    Learn
    Colorectal cancer basicsCancer screeningRisk factorsEarly-onset colorectal cancer
    Treatment
    Cancer treatmentCancer surgeryChemotherapyRadiation therapyImmunotherapyTargeted therapyLiver directed therapy
    GCCA Membership Hub Preview

    GCCA Membership Hub

    Your place for collaboration, resource-sharing, and community across the global CRC network.
    Learn more
    Arrow Right
  • Get involved
    Contact
    Contact usDonate nowBecome a memberBecome a speaker
    Our members
    Member OrganizationsCorporate MembersBecome a memberFind a member
    GCCA Membership Hub Preview

    GCCA Membership Hub

    Your place for collaboration, resource-sharing, and community across the global CRC network.
    Learn more
    Arrow Right
  • Resources
    Learn
    Blog
    Toolkits
    Patient AdvocateTransforming PolicyKnow Your Biomarker Advocacy
    GCCA Membership Hub Preview

    GCCA Membership Hub

    Your place for collaboration, resource-sharing, and community across the global CRC network.
    Learn more
    Arrow Right
  • Donate now
Donate now
GCCA Blog
Research
Categories
  • Advocacy
  • Biomarkers
  • Clinical Trials
  • CRC Awareness
  • Health Equity
  • Members Monthly Meetings
  • Member Spotlight
  • Mentorship
  • News
  • Patient Stories
  • Policy
  • Research

Research

CRC Research
20 Oct
2026

Two New Immunotherapy Approvals for Colorectal Cancer

Atezolizumab and dostarlimab approved in select colorectal cancers.
GCCA
|
3
min read
26 Aug
2026

Chemoradiotherapy and Radiotherapy for Colorectal Cancer: What Patients Need to Know

What are chemoradiotherapy and radiotherapy? What did the STAR-TREC study find?
GCCA
|
4
min read
19 Aug
2026

Colon Cancer vs. Rectal Cancer vs. Bowel Cancer: What’s the Difference?

Colon cancer and rectal cancer are both colorectal cancer, but are there differences?
GCCA
|
5
min read
3 Aug
2026

Cancer Vaccines Are Coming for Colorectal Cancer

New cancer vaccines may help the immune system prevent colorectal cancer recurrence.
GCCA
|
5
min read
27 Jul
2026

Putting Patients and Communities at the Center of Colorectal Cancer Research: The CRC-Gen Study

GCCA collaborates on an important genetic study in South Africa.
GCCA
|
3
min read
Global Colon Cancer Association Logo
Global Colon Cancer Association is a 501(c)3 not-for-profit organization with Tax ID No: 46-0657002

INFORMATION ON THIS WEB SITE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND IS NOT A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE

About us

AboutBecome a memberFind a memberProgram overviewContact us

Our programs

Know Your BiomarkerTransforming PolicyGlobal CRC CongressCRC Health Equity GrantsPatient Advocacy MentorshipClinical Trial AwarenessColon Cancer Connected

Join the movement

Get the latest news & updates
  • © Global Colon Cancer Association 2025
  • Privacy policy
  • Cookie preferences
Research
Patient Stories
Members Monthly Meetings
Mentorship
CRC Awareness
Clinical Trials
Biomarkers
Health Equity
Advocacy
News
Member Spotlight
Policy